Clinical Trial Search

Primary: 2-year PFS From the Start of Induction Therapy Conditional — 86.6; 90.6; 0.4 percentage of patients

Primary: 1 Year Progression-free Survival Rate — 0.74 percentage of participants

Primary: Progression-free Survival — 89 percentage of participants

Primary: Proportion of Patients With CNS Involvement by B-cell NHL, Relapsed PCNSL, or Relapsed PIOL Who Are Alive and Progression-free at One Year — 28 Participants

Primary: Overall Response (Complete Response + Partial Response) — 216; 94 Participants

Primary: Number of Participants in Complete Remission 6 Months After Randomization — 14; 9 Participants

Primary: Number of Participants With Time to Progression (TTP) — 42; 4 Participants

Primary: Complete Remission — 10 participants

Primary: Disease-free Survival — 76; 88; 70 percentage of participant

Primary: Percentage of Patients With Complete Response to the Combination Chemotherapy — 75.0; 23.0 Percentage of participants

Primary: 2-year Overall Survival Rates — 71.1; 73.7 percentage of participants

Primary: 2-year Progression-Free Survival (PFS) — 0.76; 0.42 probability

Primary: Survival at 1 Year After Transplantation — 10; 6 participants

Primary: 3 Years Event-free Survival — 51; 56; 126; 123 Participants

Primary: Complete Response Proportion as Measured by Tumor Response After Completion of Study Treatment — 0.69; 0.53 proportion

Primary: Percentage of Participants With 3-year Progression-free Survival (PFS) — 90 percentage of participants

Primary: Response Rate of Patients After 2 Courses of Chemotherapy — 45.2; 44.0 percentage of response — p=0.005

Primary: Response Rate = Complete and Partial Response at 12 Weeks. — 5; 3; 2; 15 participants

Primary: Progression — 22; 1 participants — p=0.51

Primary: Event-free Survival (EFS) — 83 percentage of not experiencing EFS event

Primary: Overall Response (OR) Rate — 0.07 Proportion of participants

Primary: Progression-free Survival (PFS) at 2 Years — 69 percentage of participants

Primary: Event Free Survival — 65; 62 percentage of EFS at 3 years follow-up — p=<0.05

Primary: Progression-Free Survival Rate at 2 and 5 Years — 78.9; 75.5; 68.0; 66.0 percentage of participants — p=0.6519

Primary: Improve the Overall Response Rate — 4; 2; 7; 4 participants

Primary: Clinical Response Rate — 1; 7; 0; 8 Participants

Primary: Overall Survival at 1 Year — 90 percentage of participants

Primary: Progression-free Survival at 1 Year — 38 percentage of participants

Primary: Tumor Response Rate (RR) (Percentage of Participants Exhibiting Complete Response [CR] or Complete Response Unconfirmed [CRu] or Partial Response [PR]) — 0; 0; 0; 0…

Primary: Number of Patients Achieving Complete Response (CR) — 4; 32 Participants